| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
group | 0.400 | None | 0.955 | 535 | 2 | 1994 | 2020 | ||||||||
|
androgen receptor | 0.351 | 0.846 | 0.99 |
|
group | 0.200 | None | 0.972 | 530 | 5 | 1990 | 2020 | ||||||||
|
CD44 molecule (Indian blood group) | 0.363 | 0.962 | 2.4E-07 |
|
group | 0.100 | None | 0.964 | 529 | 3 | 1991 | 2020 | ||||||||
|
ALK receptor tyrosine kinase | 0.396 | 0.846 | 3.2E-06 |
|
group | 0.100 | None | 0.979 | 517 | 15 | 1996 | 2020 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
group | 0.100 | None | 0.975 | 510 | 4 | 1989 | 2020 | ||||||||
|
CEA cell adhesion molecule 5 | 0.420 | 0.846 | 4.2E-10 |
|
group | 0.100 | None | 0.956 | 502 | 0 | 1976 | 2020 | ||||||||
|
MDM2 proto-oncogene | 0.362 | 0.846 | 1.00 |
|
group | 0.100 | None | 0.955 | 493 | 6 | 1993 | 2020 | ||||||||
|
progesterone receptor | 0.426 | 0.885 | 5.1E-02 |
|
group | 0.100 | None | 0.924 | 462 | 5 | 1985 | 2020 | ||||||||
|
MYCN proto-oncogene, bHLH transcription factor | 0.454 | 0.808 | 0.89 |
|
group | 0.100 | None | 0.951 | 449 | 0 | 1984 | 2020 | ||||||||
|
kallikrein related peptidase 3 | 0.443 | 0.885 | 4.4E-06 |
|
group | 0.100 | None | 0.931 | 433 | 3 | 1990 | 2020 | ||||||||
|
BRCA2 DNA repair associated | 0.379 | 0.846 | 2.4E-25 |
|
group | 0.100 | None | 0.958 | 431 | 9 | 1995 | 2020 | ||||||||
|
alpha fetoprotein | 0.429 | 0.885 | 1.1E-11 |
|
group | 0.100 | None | 0.960 | 428 | 3 | 1977 | 2020 | ||||||||
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
group | 0.200 | None | 0.967 | 423 | 22 | 1991 | 2020 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
group | 0.200 | None | 0.957 | 421 | 17 | 1992 | 2020 | ||||||||
|
isocitrate dehydrogenase (NADP(+)) 1 | 0.424 | 0.808 | 2.6E-12 |
|
group | 0.100 | None | 0.971 | 416 | 4 | 2009 | 2020 | ||||||||
|
interferon gamma | 0.288 | 0.962 | 0.47 |
|
group | 0.100 | None | 0.980 | 404 | 0 | 1989 | 2020 | ||||||||
|
O-6-methylguanine-DNA methyltransferase | 0.412 | 0.885 | 1.2E-07 |
|
group | 0.100 | None | 0.955 | 403 | 3 | 1992 | 2020 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
group | 0.400 | None | 0.947 | 392 | 4 | 1987 | 2020 | ||||||||
|
microRNA 21 | 0.363 | 0.846 |
|
group | 0.100 | None | 0.974 | 388 | 1 | 2006 | 2020 | |||||||||
|
Ras association domain family member 1 | 0.420 | 0.808 | 4.9E-06 |
|
group | 0.100 | None | 0.974 | 381 | 2 | 2000 | 2020 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
group | 0.100 | None | 0.975 | 354 | 4 | 1990 | 2020 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
group | 0.100 | None | 0.977 | 352 | 0 | 1992 | 2020 | ||||||||
|
interleukin 2 | 0.336 | 0.885 | 0.48 |
|
group | 0.400 | None | 0.974 | 351 | 0 | 1984 | 2020 | ||||||||
|
MET proto-oncogene, receptor tyrosine kinase | 0.380 | 0.846 | 0.97 |
|
group | 0.100 | None | 0.949 | 350 | 10 | 1992 | 2020 | ||||||||
|
ret proto-oncogene | 0.392 | 0.885 | 1.00 |
|
group | 0.200 | None | 0.940 | 335 | 8 | 1989 | 2020 |